Last reviewed · How we verify
PrOpsynvi® Film-Coated Tablets
PrOpsynvi® Film-Coated Tablets is a Small molecule drug developed by Humanis Saglık Anonim Sirketi. It is currently in Phase 1 development.
At a glance
| Generic name | PrOpsynvi® Film-Coated Tablets |
|---|---|
| Sponsor | Humanis Saglık Anonim Sirketi |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg (PHASE1)
- Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PrOpsynvi® Film-Coated Tablets CI brief — competitive landscape report
- PrOpsynvi® Film-Coated Tablets updates RSS · CI watch RSS
- Humanis Saglık Anonim Sirketi portfolio CI
Frequently asked questions about PrOpsynvi® Film-Coated Tablets
What is PrOpsynvi® Film-Coated Tablets?
PrOpsynvi® Film-Coated Tablets is a Small molecule drug developed by Humanis Saglık Anonim Sirketi.
Who makes PrOpsynvi® Film-Coated Tablets?
PrOpsynvi® Film-Coated Tablets is developed by Humanis Saglık Anonim Sirketi (see full Humanis Saglık Anonim Sirketi pipeline at /company/humanis-sagl-k-anonim-sirketi).
What development phase is PrOpsynvi® Film-Coated Tablets in?
PrOpsynvi® Film-Coated Tablets is in Phase 1.